Normahani Pasha, Khan Bilal, Sounderajah Viknesh, Poushpas Sepideh, Anwar Muzaffar, Jaffer Usman
Imperial Vascular Unit, Imperial College Healthcare NHS Trust, London, UK.
St Marys Hospital, Level 2, Patterson Building, Paddington, W21NY, UK.
Ultrasound J. 2021 Feb 19;13(1):8. doi: 10.1186/s13089-021-00208-8.
This review aims to summarise the contemporary uses of intraoperative completion Duplex ultrasound (IODUS) for the assessment of lower extremity bypass surgery (LEB) and carotid artery endarterectomy (CEA).
We performed a systematic literature search using the databases of MEDLINE. Eligible studies evaluated the use of IODUS during LEB or CEA.
We found 22 eligible studies; 16 considered the use of IODUS in CEA and 6 in LEB. There was considerable heterogeneity between studies in terms of intervention, outcome measures and follow-up. In the assessment of CEA, there is conflicting evidence regarding the benefits of completion imaging. However, analysis from the largest study suggests a modest reduction in adjusted risk of stroke/mortality when using IODUS selectively (RR 0.74, CI 0.63-0.88, p = 0.001). Evidence also suggests that uncorrected residual flow abnormalities detected on IODUS are associated with higher rates of restenosis (range 2.1% to 20%). In the assessment of LEB, we found a paucity of evidence when considering the benefit of IODUS on patency rates or when considering its utility as compared to other imaging modalities. However, the available evidence suggests higher rates of thrombosis or secondary intervention in grafts with uncorrected residual flow abnormalities (up to 36% at 3 months).
IODUS can be used to detect defects in both CEA and LEB procedures. However, there is a need for more robust prospective studies to determine the best scanning strategy, criteria for intervention and the impact on clinical outcomes.
本综述旨在总结术中完成双功超声(IODUS)在评估下肢旁路手术(LEB)和颈动脉内膜切除术(CEA)中的当代应用。
我们使用MEDLINE数据库进行了系统的文献检索。符合条件的研究评估了IODUS在LEB或CEA中的应用。
我们找到了22项符合条件的研究;16项考虑了IODUS在CEA中的应用,6项考虑了其在LEB中的应用。在干预措施、结局指标和随访方面,研究之间存在相当大的异质性。在CEA评估中,关于完成成像的益处存在相互矛盾的证据。然而,最大规模研究的分析表明,选择性使用IODUS时,中风/死亡率的调整风险略有降低(RR 0.74,CI 0.63 - 0.88,p = 0.001)。证据还表明,IODUS检测到的未校正残余血流异常与更高的再狭窄率相关(范围为2.1%至20%)。在LEB评估中,考虑IODUS对通畅率的益处或与其他成像方式相比的效用时,我们发现证据不足。然而,现有证据表明,存在未校正残余血流异常的移植物中血栓形成或二次干预的发生率更高(3个月时高达36%)。
IODUS可用于检测CEA和LEB手术中的缺陷。然而,需要更有力的前瞻性研究来确定最佳扫描策略、干预标准以及对临床结局的影响。